Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ...

FDA Drug Recall #D-0291-2015 — Class III — December 5, 2014

Recall Summary

Recall Number D-0291-2015
Classification Class III — Low risk
Date Initiated December 5, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Sandoz Incorporated
Location Broomfield, CO
Product Type Drugs
Quantity 1,008 bottles

Product Description

Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01

Reason for Recall

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Distribution Pattern

AZ

Lot / Code Information

Lot ET5122, Exp. 10/17

Other Recalls from Sandoz Incorporated

Recall # Classification Product Date
D-0631-2018 Class III Triamterene and Hydrochlorothiazide Tablets, US... Apr 6, 2018
D-0943-2017 Class III Amitriptyline HCl Tablets, USP 25 mg, Packaged ... Jun 16, 2017
D-0236-2017 Class II Nadolol Tablets, USP, 40mg, packaged in 1000-co... Dec 22, 2016
D-1509-2014 Class II Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 ... Jul 25, 2014
D-383-2014 Class II Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/... Oct 22, 2013

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.